Prof. Stephen Stahl - One Neurotransmitter to rule them all: The Serotonin Network Ver ponencia Casos clínicos: Dr. Pedro Iborra Ver ponencia Casos clínicos: Dra. Elena Ros Ver ponencia Casos clínicos: Dra. Ángeles Sánchez-Cabezudo Muñoz Ver ponencia Iluminando la recuperación del paciente: embotamiento emocional y anhedonia Ver ponencia Iluminando el entorno social: Mobbing y Depresión Ver ponencia Entrevista al experto: Prof. Stephen Stahl Ver Entrevista Entrevista al experto: Dr. Guillermo Lahera Ver entrevista Entrevista al experto: Dra. Rosa Gutierrez Ver entrevista Visite las presentaciones de nuestros ponentes que tuvieron lugar durante la reunión de Avanzando en depresión: Iluminando el futuro Depression 30 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights in depression research from APA Online 2022 Recent research findings in depression from the poster session at APA Online 2022 covered topics... Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Alzheimer's Disease, Parkinson's Disease 20 Sep, 2022 Read Time: 3 mins Congress highlights Article Will artificial intelligence replace or augment physicians? Artificial intelligence (AI) is already disrupting healthcare in many areas. Will it eventually... Migraine 19 Sep, 2022 Read Time: 3 mins Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine When measuring the success of migraine treatment, it is easy to focus on clinical features like... Migraine 15 Sep, 2022 Read Time: 3 mins Satellite symposium Article Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,... Migraine 13 Sep, 2022 Read Time: 5 mins Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice Three experts from different countries provided perspectives on their own clinical practice managing... Migraine 12 Sep, 2022 Read Time: 3 mins Congress highlights Article Raising the healthcare prioritization of headache: Why and how? Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor... Migraine 12 Sep, 2022 Read Time: 4 mins Satellite symposium Article New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention... Schizophrenia 07 Sep, 2022 Read Time: 3 mins Congress highlights Article Interventions to improve real-life functioning Accurate assessment of neurocognition and social cognition and personalized cognitive training and... Migraine 30 Aug, 2022 Read Time: 3 mins Satellite symposium Article What can be done to lower the economic cost of migraine? The annual economic cost of migraine is high — estimated to be €50–111 billion in Europe in 2011.... Mental Health 24 Aug, 2022 Read Time: 3 mins Congress highlights Article How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Load More Depression 12 May, 2023 Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM? Other Conferences ECNP 2021 Hybrid congress October 2-5 COVID-19 pandemic: impact on brain health CONTENT SELECTION San Francisco Congress APA 2019 Cloned Date 2020/02/12 08:02:20 Clone source Id 5779 Clone source uuid 86789347-e8f2-497b-9ba6-f2eacf8f6556
